Cancer Research KI
Cancer Research KI is an overarching umbrella organisation of cancer research at Karolinska Institutet, that includes more than 350 research groups. The aim is to combine cancer research with clinical oncology by bringing together top level cancer scientists from different disciplines, with the goal to aid generating new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society.
The Cancer Research KI missions
Promoting Research
Educating
Stimulating collaborations
6th Swedish Cancer Research Meeting 16-17th of May 2023
16-17th of May 2023: 6th Cancer Swedish Research Meeting
The meeting is open to all clinical, preclinical researchers and others with an interest in cancer research from the organizing universities.
Venue: Karolinska Institutet, Aula Medica, Erling Persson-salen, Nobels väg 6, 171 65 Solna
Host: Cancer Research KI
Registration will open in week 7
Organizers: U-CAN from Uppsala/Umeå Universities, LUCC (Lund University Cancer Centre), University of Gothenburg, and Cancer Research KI from Karolinska Institutet.
Cancer Research KI News
Blue Sky Grant 2022 recipients
Cancer Research KI has opened a call for up to six project grants in cancer research for well-defined innovative pilot projects that aim to demonstrate proof of principle.
Deadline: the 17th of October 2022, 2pm
Lecture by this year’s Sjöberg Laureate Prof. Kevan M. Shokat during the Karolinska CCC Days
Welcome to a lecture by this year's Sjöberg Laureate chemist Kevan M. Shokat from the USA. Ten years ago, he became the first person to succeed in blocking one of the mutated proteins that cause most cancer cases. This is a huge scientific breakthrough that is bringing hope to people who are critically ill with lung cancer.
Collaborative Call: 2023 Karolinska Institutet and Mayo Clinic Cancer Center
The Mayo Clinic Comprehensive Cancer Center and Karolinska Institutet are pleased to announce the 2023 Request for Applications (RFA) within the areas of breast cancer, other solid tumors, and hematologic malignancies with a submission deadline of March 31, 2023.
Karolinska CCC - days 30-31 March 2023, Aula Medica
Registration has been prolonged until 24th of March.
Research aiming to knock out every cancer cell!
Please check out the interview with Klas Wiman och Galina Selivanova for Radiumhemmets Forskningsfonder.
Photo: Gonzalo Irigoyen for Radiumhemmets Forskningsfonder.
På jakt efter tumörernas akilleshäl
Radiumhemmets forskningsfonder interview with Martin Enge, PhD from the Dept. of Oncology-Pathology KI.
(text in Swedish)
Call for nomination to the Cancer Research KI Executive Board
In Autumn 2022, Cancer Research KI will elect three or four (3-4) members to the CRKI Executive board and the CRKI Nomination Committee hereby open the call for nominations.
Deadline: September 15th, 2022
2022 KI- Mayo Collaborative grant recipients
The Mayo Clinic Cancer Center and Cancer Research K are pleased to announce the 2022 recipients of the collaborative grants supporting Breast Cancer, other Solid Tumors, and Hematologic Malignancies research.
Cancer Research KI aims to increase your visibility to attract internal, international, industrial collaborations and funding, and to add your group to the database of cancer research at KI
The database sign-up is currently closed and being updated on the website. If you wish to add you research group to the database contact cancerresearchki@ki.se
The database is intended for all principal investigators (PI) or team leaders engaged in some form of cancer research at KI.
Cancer Research KI awards the bridging grant at the consolidator level for a junior researcher
The bridging grant provide two-year funding at the consolidator level to the highest ranked applicant who was not awarded the KI five-year consolidator grant (1.2 million SEK per year, for 2022-2023). The Bridging grant recipient is Linda Lindström, Associate Professor in Cancer Epidemiology and Group Leader at the Department of Oncology and Pathology.
Collaboration is the key to the future's cancer treatment
Anna Martling (Precision Medicine Centre Karolinska (PMCK)) and Hans-Gustaf Ljunggren (NextGenNK) in an article in the Swedish newspapper Dagens Industri. Article in Swedish.
Kirsty Spalding and Bennie Lemmens granted with The Mark Foundation for Cancer Research ASPIRE Award
The Mark Foundation for Cancer Research granted two Karolinska Institutet’s principal investigators, Dr. Kirsty Spalding and Dr. Bennie Lemmens with ASPIRE (Accelerating Scientific Platform and Innovative Research) Awards. This is the first time that The Mark Foundation has awarded researchers from Sweden. They were selected as scientists who have an innovative approach to solving impactful problems in the cancer field.
Cancer Research KI maps cancer research principal investigators across KI
Cancer Research KI has mapped the research landscape at KI and created a database with information about research groups across KI that conduct cancer research. The database is intended for researchers at KI and elsewhere as well as others interested in obtaining an overview of cancer research at KI, to foster new collaborations, learn more about specific cancer areas, or explore industrial interactions.
2021 Translational seed funding grant recipients
Congratulations to all the Translational seed funding grant recipients of 2021.
Strengthened collaboration with Hungary in the field of cancer
SAVE THE DATE
Cancer Research KI retreat at Djurönäset 25-26 September, 2023
The XXth Cancer Research KI Retreat will take place on September 25-26, 2023 at Djurönäset in the Stockholm archipelago, gathering Cancer Researchers from Karolinska Institutet and University Hospital for an annual joint scientific meeting.
Seminars and Workshops
Industry-academia collaborations, seminar series by Cancer Reseach KI
Welcome to the seminar organised by Cancer Research KI.
Date and time: 23rd of March
Title: How to collaborate with academia the company perspective
Venue: Inghesalen, Tomtebodavägen 18a
Please join us to listen to several companies that have experience from both collaborating with academia as well as has sprung out of academia. Programme and registration will be published soon.
Cancer Workshop for Patient Organisations
In collaboration with RCC Stockholm-Gotland, Cancer Research KI, organises a digital workshop in cancer for patient organisations. The workshop is in Swedish and gives opportunities for interaction and communication between cancer patient organisations and researchers.
Course in Clinical cancer epidemiology: From prevention to treatment and patient care
Researchers at King’s College London (KCL) and Karolinska Institutet (KI) are collaborating in organising a course entitled Clinical cancer epidemiology: From prevention to treatment and patient care.
16th of November 2022: En dag för cancerforskning Karolinska Institutet
16th of November 2022: En dag för cancerforskning Karolinska Institutet
Under dagen samlades forskare och för att berätta om den banbrytande cancerforskning de arbetar med. Kolla in programmet från förra året och håll utkik för mer information (The day is held in Swedish).
Grant Announcements
Collaborative Call: 2023 Karolinska Institutet and Mayo Clinic Cancer Center
The Mayo Clinic Comprehensive Cancer Center and Karolinska Institutet are pleased to announce the 2023 Request for Applications (RFA) within the areas of breast cancer, other solid tumors, and hematologic malignancies with a submission deadline of March 31, 2023.
Blue Sky Grant 2022 recipients
Cancer Research KI has opened a call for up to six project grants in cancer research for well-defined innovative pilot projects that aim to demonstrate proof of principle.
Deadline: the 17th of October 2022, 2pm
